Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
8%
ALSO IN OZEM
OZEM
22
HOLDINGS
24%
ALSO IN XLV
SECTOR DRIFT (XLV minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.8% | 15.3% | 14.8% |
|
AMGEN INC | 3.1% | 3.5% | 3.1% |
|
PFIZER INC | 2.5% | 4.0% | 2.5% |
|
GILEAD SCIENCES INC | 2.6% | 1.8% | 1.8% |
|
REGENERON PHARMACEUTICALS | 1.4% | 2.8% | 1.4% |
XLV Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 8.6% |
|
ABBVIE INC | 6.8% |
|
UNITEDHEALTH GROUP INC | 5.5% |
|
MERCK & CO. INC. | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
ABBOTT LABORATORIES | 3.8% |
|
INTUITIVE SURGICAL INC | 3.6% |
|
DANAHER CORP | 2.6% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
|
STRYKER CORP | 2.2% |
XLV Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -22.0% |
 |
ROCHE HOLDING LTD | -4.2% |
|
ZEALAND PHARMA A/S | -3.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.9% |
 |
ASCLETIS PHARMA, INC. | -3.6% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
 |
HANMI PHARM CO LTD | -3.4% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.3% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.2% |